T. John Winhusen, Phd
Clinical trials sponsored by T. John Winhusen, Phd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A new approach to bridge the gap: can personalized education boost opioid treatment uptake? Results expected Feb 2027 (estimated)
-
A new approach to bridge the gap: can personalized education boost opioid treatment uptake?
Disease control Recruiting nowThis pilot trial tests a program called TRTME, designed to help hospitalized patients with opioid use disorder begin medication treatment after discharge. The program includes personalized education to correct misconceptions about MOUD, feedback on individual overdose risk factor…
Sponsor: T. John Winhusen, PhD • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a diabetes drug help fight opioid addiction?
Disease control Recruiting nowThis study tests whether tirzepatide, a drug used for diabetes and weight loss, can help people with moderate to severe opioid use disorder stay in treatment and use fewer opioids when added to their regular buprenorphine medication. About 310 adults who recently started buprenor…
Phase 2 • Sponsor: T. John Winhusen, PhD • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC